Targeted Strategies for Today's Evolving Markets

MissionIR Blog

AeternaZentaris (AEZS) Presents at Rodman & Renshaw Conference

AeternaZentaris, Inc. (NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in the development and commercialization of novel treatments in the fields of oncology, endocrinology and women’s health. The company’s product pipeline includes Macrilen™, which is currently in phase III clinical testing for the diagnosis of adult growth hormone deficiency, as well as zoptarelin doxorubicin, which is in phase III clinical development for the treatment of endometrial cancer. For more information, visit the company’s website at www.aezsinc.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Comments are closed.